Jay R. Luly

Insider Reports History

Entity
Individual
Location
C/O Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jay R. Luly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC President and CEO, Director Common Stock 811K $10.1M $12.41 Feb 12, 2024 Direct
ENANTA PHARMACEUTICALS INC President and CEO, Director Stock Option (right to buy) 264K Nov 22, 2023 Direct

Insider Reports Filed by Jay R. Luly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENTA ENANTA PHARMACEUTICALS INC Feb 12, 2024 2 -$19.7K 4 Feb 14, 2024 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Dec 5, 2023 1 -$69.6K 4 Dec 6, 2023 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2023 1 -$54.9K 4 Dec 5, 2023 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Nov 22, 2023 1 $0 4 Nov 22, 2023 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Mar 13, 2023 5 -$870K 4 Mar 14, 2023 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Feb 13, 2023 3 -$1.09M 4/A Feb 15, 2023 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Dec 19, 2022 2 $400K 4 Dec 19, 2022 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Dec 16, 2022 7 -$919K 4 Dec 16, 2022 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2022 1 -$251K 4 Dec 5, 2022 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Nov 23, 2022 2 $0 4 Nov 28, 2022 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Feb 14, 2022 3 -$147K 4 Feb 15, 2022 President and CEO
ENTA ENANTA PHARMACEUTICALS INC Jan 15, 2022 2 $118K 4 Jan 18, 2022 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2021 1 -$170K 4 Dec 3, 2021 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Nov 19, 2021 2 $0 4 Nov 23, 2021 President and CEO, Director
ENTA ENANTA PHARMACEUTICALS INC Sep 15, 2021 1 -$267K 4 Sep 17, 2021 President and CEO, Director